The dual role of TLR3 in metastatic cell line
Tanja Matijevic1, Jasminka Pavelic
1Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka, Zagreb, Croatia.
Abstract:
Toll-like receptors (TLRs) are members of transmembrane proteins that recognize conserved molecular motifs of viral and bacterial origin and initiate innate immune response. As the role of TLRs in tumors cells is still not clear, our aim was to investigate the role of TLR3 in primary tumor and metastatic cells (SW480, SW620, FaDu and Detroit 562). We have reported here on the dual role of TLR3 in pharynx metastatic cell line (Detroit 562); on one hand TLR3 activation drove cells to apoptosis while on the other its stimulation contributed to tumor progression by altering the expression of tumor promoting genes (PLAUR, RORB) and enhancing the cell migration potential. In addition, we have shown TLR3 signaling pathway is functional in another metastatic cancer cell line (SW620) suggesting TLR3 might be important in the process of tumor metastasis. Since TLR3 agonists have been used in tumor therapy with the aim to activate immune system, scientific contribution of this work is drawing attention to the importance of further work on this topic, especially pro-tumor effect of TLR3, in order to avoid possible side-effects.
Insights
Toll-like receptor 3 (TLR3) has a dual role in cancer cells, potentially inducing apoptosis or promoting tumor progression and metastasis. Further research is crucial to understand its pro-tumor effects and avoid adverse effects in cancer therapy.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Toll-like receptors (TLRs) are key transmembrane proteins in innate immunity, recognizing pathogen-associated molecular patterns.
- The specific role of TLRs, particularly TLR3, within tumor cells remains incompletely understood.
- Investigating TLR3's function in cancer is critical for understanding tumor development and therapeutic strategies.
Purpose of the Study:
- To elucidate the function of Toll-like receptor 3 (TLR3) in primary and metastatic cancer cell lines.
- To determine the impact of TLR3 activation on apoptosis, gene expression, and cell migration in specific cancer models.
- To assess the potential dual role of TLR3 in tumor progression and metastasis.
Main Methods:
- Utilized human cancer cell lines (SW480, SW620, FaDu, Detroit 562) representing primary and metastatic tumors.
- Investigated TLR3 activation and its downstream effects on cellular processes.
- Analyzed changes in gene expression, including tumor-promoting genes like PLAUR and RORB.
- Assessed cell migration potential and induction of apoptosis.
Main Results:
- TLR3 activation demonstrated a dual role in the Detroit 562 metastatic pharyngeal cell line, inducing apoptosis while also promoting tumor progression.
- TLR3 stimulation enhanced cell migration and altered the expression of tumor-promoting genes (PLAUR, RORB).
- The TLR3 signaling pathway was confirmed to be functional in the SW620 metastatic cancer cell line, suggesting its significance in metastasis.
Conclusions:
- TLR3 exhibits a complex, potentially dual role in cancer, capable of both inducing apoptosis and promoting tumor progression and metastasis.
- The findings highlight the importance of considering the pro-tumorigenic effects of TLR3 activation in cancer therapy.
- Further investigation into TLR3's specific functions is warranted to optimize its therapeutic application and mitigate potential side effects.
More Related Videos
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:17The Tumor Microenvironment